Increased investment and clinical trials in regenerative medicine support demand.

Increased investment and clinical trials in regenerative medicine support demand. The global stem cell therapy market is projected to grow from about $0.48b in 2026 to $3.65b by 2035, according to MarketsandMarketsTM. Growth is being driven by the rising prevalence of chronic and degenerative diseases, increased investment in regenerative medicine, and expanding clinical trials for stem cell-based treatments. Advances in induced pluripotent stem cell (iPSC) technology and the growing use of allo